Frequently Asked Questions (FAQs)

A Scientometric Review of Genome-Wide Association Studies

Journal: Communications Biology

DOI: 10.1038/s42003-018-0261-x

Authors: M.C. Mills & C. Rahal
Affiliation: University of Oxford and Nuffield College
Correspondence: Professor Melinda Mills, Nuffield College, 1 New Road, Oxford, OX1 1NF, UK.
E-mail: melinda.mills@nuffield.ox.ac.uk

This FAQ provides a range of accessible answers to some of the questions you might have regarding our article. Please note that given the 'live', on-going nature of the project, the figures featured in the GitHub repository will update and may not concur exactly with those in the published article.
 

  1. What do we study?

  2. How did we study it?

  3. What are some of the central findings?

  4. What are the medical, societal, scientific and commercial implications of this study? Our study is crucial for researchers, data providers, editors and consortiums working in this area to understand the strengths and potential gaps in current research and is essential to plan future investments in data collection and science policy for funders, research bodies and national governments. Growing investments from pharmaceutical companies are being made in this area to translate this research into drugs. Our study highlights that the genetic findings to date are of highly selective populations, coming largely from 3 countries and are often not representative of the wider global population. We offer ten concrete evidence-based policy recommendations:

  5. Additional general questions (updated over time as we receive additional questions)

  6. References